Skip to main content

05.04.2024 | Therapy in Practice

Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses

verfasst von: Romain Salle, Pascal Del Giudice, Charbel Skayem, Camille Hua, Olivier Chosidow

Erschienen in: American Journal of Clinical Dermatology

Einloggen, um Zugang zu erhalten

Abstract

Secondary bacterial infections of common dermatoses such as atopic dermatitis, ectoparasitosis, and varicella zoster virus infections are frequent, with Staphylococcus aureus and Streptococcus pyogenes being the bacteria most involved. There are also Gram-negative infections secondary to common dermatoses such as foot dyshidrotic eczema and tinea pedis. Factors favoring secondary bacterial infections in atopic dermatitis, ectoparasitosis, and varicella zoster virus infections mainly include an epidermal barrier alteration as well as itch. Mite-bacteria interaction is also involved in scabies and some environmental factors can promote Gram-negative bacterial infections of the feet. Furthermore, the bacterial ecology of these superinfections may depend on the geographical origin of the patients, especially in ectoparasitosis. Bacterial superinfections can also have different clinical aspects depending on the underlying dermatoses. Subsequently, the choice of class, course, and duration of antibiotic treatment depends on the severity of the infection and the suspected bacteria, primarily targeting S. aureus. Prevention of these secondary bacterial infections depends first and foremost on the management of the underlying skin disorder. At the same time, educating the patient on maintaining good skin hygiene and reporting changes in the primary lesions is crucial. In the case of recurrent secondary infections, decolonization of S. aureus is deemed necessary, particularly in atopic dermatitis.
Literatur
1.
Zurück zum Zitat Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.CrossRef Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.CrossRef
2.
Zurück zum Zitat Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527–34.PubMedCrossRef Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527–34.PubMedCrossRef
3.
Zurück zum Zitat Sandhu JK, Salame N, Ehsani-Chimeh N, Armstrong AW. Economic burden of cutaneous infections in children and adults with atopic dermatitis. Pediatr Dermatol. 2019;36:303–10.PubMedCrossRef Sandhu JK, Salame N, Ehsani-Chimeh N, Armstrong AW. Economic burden of cutaneous infections in children and adults with atopic dermatitis. Pediatr Dermatol. 2019;36:303–10.PubMedCrossRef
4.
Zurück zum Zitat Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32:850–78.PubMedCrossRef Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32:850–78.PubMedCrossRef
5.
Zurück zum Zitat Marcus E, Demmler D, Rudolph A, Fischer M. Bacterial colonization of psoriasis plaques. Is it relevant? Dermatol Rep. 2011;3: e14.CrossRef Marcus E, Demmler D, Rudolph A, Fischer M. Bacterial colonization of psoriasis plaques. Is it relevant? Dermatol Rep. 2011;3: e14.CrossRef
6.
Zurück zum Zitat Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–60.PubMedCrossRef Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–60.PubMedCrossRef
7.
Zurück zum Zitat Totté JEE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SGMA. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2016;175:687–95.PubMedCrossRef Totté JEE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SGMA. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2016;175:687–95.PubMedCrossRef
8.
Zurück zum Zitat Ong PY, Leung DYM. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51:329–37.PubMedCrossRef Ong PY, Leung DYM. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51:329–37.PubMedCrossRef
9.
Zurück zum Zitat Wang V, Keefer M, Ong PY. Antibiotic choice and methicillin-resistant Staphylococcus aureus rate in children hospitalized for atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122:314–7.PubMedCrossRef Wang V, Keefer M, Ong PY. Antibiotic choice and methicillin-resistant Staphylococcus aureus rate in children hospitalized for atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122:314–7.PubMedCrossRef
10.
Zurück zum Zitat Mannschreck D, Feig J, Selph J, Cohen B. Disseminated bullous impetigo and atopic dermatitis: case series and literature review. Pediatr Dermatol. 2020;37:103–8.PubMedCrossRef Mannschreck D, Feig J, Selph J, Cohen B. Disseminated bullous impetigo and atopic dermatitis: case series and literature review. Pediatr Dermatol. 2020;37:103–8.PubMedCrossRef
11.
Zurück zum Zitat Liy-Wong C, Pope E, Weinstein M, Lara-Corrales I. Staphylococcal scalded skin syndrome: an epidemiological and clinical review of 84 cases. Pediatr Dermatol. 2021;38:149–53.PubMedCrossRef Liy-Wong C, Pope E, Weinstein M, Lara-Corrales I. Staphylococcal scalded skin syndrome: an epidemiological and clinical review of 84 cases. Pediatr Dermatol. 2021;38:149–53.PubMedCrossRef
12.
Zurück zum Zitat Vernali S, Blasiak RC, Morrell DS. Demographic characteristics, clinical features, and optimal management of hospitalized patients with staphylococcal scalded skin syndrome. Pediatr Dermatol. 2021;38:825–30.PubMedCrossRef Vernali S, Blasiak RC, Morrell DS. Demographic characteristics, clinical features, and optimal management of hospitalized patients with staphylococcal scalded skin syndrome. Pediatr Dermatol. 2021;38:825–30.PubMedCrossRef
13.
Zurück zum Zitat Petry V, Bessa GR, Poziomczyck CS, de Oliveira CF, Weber MB, Bonamigo RR, et al. Bacterial skin colonization and infections in patients with atopic dermatitis. An Bras Dermatol. 2012;87:729–34.PubMedCrossRef Petry V, Bessa GR, Poziomczyck CS, de Oliveira CF, Weber MB, Bonamigo RR, et al. Bacterial skin colonization and infections in patients with atopic dermatitis. An Bras Dermatol. 2012;87:729–34.PubMedCrossRef
14.
Zurück zum Zitat David Boothe W, Tarbox JA, Tarbox MB. Atopic dermatitis: pathophysiology. Adv Exp Med Biol. 2017;1027:21–37.PubMedCrossRef David Boothe W, Tarbox JA, Tarbox MB. Atopic dermatitis: pathophysiology. Adv Exp Med Biol. 2017;1027:21–37.PubMedCrossRef
15.
Zurück zum Zitat Groner A, Laing-Grayman D, Silverberg NB. Outpatient pediatric community-acquired methicillin-resistant Staphylococcus aureus: a polymorphous clinical disease. Cutis. 2008;81:115–22.PubMed Groner A, Laing-Grayman D, Silverberg NB. Outpatient pediatric community-acquired methicillin-resistant Staphylococcus aureus: a polymorphous clinical disease. Cutis. 2008;81:115–22.PubMed
16.
Zurück zum Zitat Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155:680–7.PubMedCrossRef Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155:680–7.PubMedCrossRef
17.
Zurück zum Zitat Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42:756–66.PubMedPubMedCentralCrossRef Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42:756–66.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Silverberg JI, Silverberg NB. Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study. J Allergy Clin Immunol. 2014;133:1041–7.PubMedCrossRef Silverberg JI, Silverberg NB. Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study. J Allergy Clin Immunol. 2014;133:1041–7.PubMedCrossRef
19.
Zurück zum Zitat Parsons JB, Yao J, Frank MW, Jackson P, Rock CO. Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J Bacteriol. 2012;194:5294–304.PubMedPubMedCentralCrossRef Parsons JB, Yao J, Frank MW, Jackson P, Rock CO. Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J Bacteriol. 2012;194:5294–304.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Ong PY, Leung DYM. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep. 2006;6:384–9.PubMedCrossRef Ong PY, Leung DYM. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep. 2006;6:384–9.PubMedCrossRef
21.
Zurück zum Zitat Humeau M, Boniface K, Bodet C. Cytokine-mediated crosstalk between keratinocytes and T cells in atopic dermatitis. Front Immunol. 2022;13: 801579.PubMedPubMedCentralCrossRef Humeau M, Boniface K, Bodet C. Cytokine-mediated crosstalk between keratinocytes and T cells in atopic dermatitis. Front Immunol. 2022;13: 801579.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Strober W. Susceptibility of atopic dermatitis versus psoriasis to superinfection is related to production of β-defensins. Curr Allergy Asthma Rep. 2004;4:63–4.CrossRef Strober W. Susceptibility of atopic dermatitis versus psoriasis to superinfection is related to production of β-defensins. Curr Allergy Asthma Rep. 2004;4:63–4.CrossRef
23.
Zurück zum Zitat Francis NA, Ridd MJ, Thomas-Jones E, Butler CC, Hood K, Shepherd V, et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann Fam Med. 2017;15:124–30.PubMedPubMedCentralCrossRef Francis NA, Ridd MJ, Thomas-Jones E, Butler CC, Hood K, Shepherd V, et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann Fam Med. 2017;15:124–30.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Galli L, Venturini E, Bassi A, Gattinara GC, Chiappini E, Defilippi C, et al. Common community-acquired bacterial skin and soft-tissue infections in children: an intersociety consensus on impetigo, abscess, and cellulitis treatment. Clin Ther. 2019;41:532-51.e17.PubMedCrossRef Galli L, Venturini E, Bassi A, Gattinara GC, Chiappini E, Defilippi C, et al. Common community-acquired bacterial skin and soft-tissue infections in children: an intersociety consensus on impetigo, abscess, and cellulitis treatment. Clin Ther. 2019;41:532-51.e17.PubMedCrossRef
25.
Zurück zum Zitat Brazel M, Desai A, Are A, Motaparthi K. Staphylococcal scalded skin syndrome and bullous impetigo. Medicina (Kaunas). 2021;57:1157.PubMedCrossRef Brazel M, Desai A, Are A, Motaparthi K. Staphylococcal scalded skin syndrome and bullous impetigo. Medicina (Kaunas). 2021;57:1157.PubMedCrossRef
26.
Zurück zum Zitat Patel GK, Finlay AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol. 2003;4:165–75.PubMedCrossRef Patel GK, Finlay AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol. 2003;4:165–75.PubMedCrossRef
27.
Zurück zum Zitat Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol. 2014;28:1418–23.PubMedCrossRef Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol. 2014;28:1418–23.PubMedCrossRef
28.
Zurück zum Zitat Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–74.PubMedCrossRef Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–74.PubMedCrossRef
29.
Zurück zum Zitat Qualls ML, Mooney MM, Camargo CA, Zucconi T, Hooper DC, Pallin DJ. Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 1997–2007. Clin Infect Dis. 2012;55:103–5.PubMedCrossRef Qualls ML, Mooney MM, Camargo CA, Zucconi T, Hooper DC, Pallin DJ. Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 1997–2007. Clin Infect Dis. 2012;55:103–5.PubMedCrossRef
30.
Zurück zum Zitat Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10-52.PubMedCrossRef Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10-52.PubMedCrossRef
31.
Zurück zum Zitat Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 2014;27:264–301.PubMedPubMedCentralCrossRef Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 2014;27:264–301.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Patel D, Jahnke MN. Serious complications from Staphylococcal aureus in atopic dermatitis. Pediatr Dermatol. 2015;32:792–6.PubMedCrossRef Patel D, Jahnke MN. Serious complications from Staphylococcal aureus in atopic dermatitis. Pediatr Dermatol. 2015;32:792–6.PubMedCrossRef
33.
Zurück zum Zitat George SM, Karanovic S, Harrison DA, Rani A, Birnie AJ, Bath-Hextall FJ, et al. Interventions to reduce Staphylococcus aureus in the management of eczema. Cochrane Database Syst Rev. 2019;2019:CD003871.PubMedPubMedCentral George SM, Karanovic S, Harrison DA, Rani A, Birnie AJ, Bath-Hextall FJ, et al. Interventions to reduce Staphylococcus aureus in the management of eczema. Cochrane Database Syst Rev. 2019;2019:CD003871.PubMedPubMedCentral
34.
Zurück zum Zitat Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LWA, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012;1:CD003261.PubMed Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LWA, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012;1:CD003261.PubMed
35.
Zurück zum Zitat Vogel A, Lennon D, Best E, Leversha A. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. N Z Med J. 2016;129:77–83.PubMed Vogel A, Lennon D, Best E, Leversha A. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. N Z Med J. 2016;129:77–83.PubMed
36.
Zurück zum Zitat Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.PubMedCrossRef Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.PubMedCrossRef
37.
Zurück zum Zitat Chen AE, Carroll KC, Diener-West M, Ross T, Ordun J, Goldstein MA, et al. Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics. 2011;127:e573–80.PubMedPubMedCentralCrossRef Chen AE, Carroll KC, Diener-West M, Ross T, Ordun J, Goldstein MA, et al. Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics. 2011;127:e573–80.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Bouchiat C, Curtis S, Spiliopoulou I, Bes M, Cocuzza C, Codita I, et al. MRSA infections among patients in the emergency department: a European multicentre study. J Antimicrob Chemother. 2017;72:372–5.PubMedCrossRef Bouchiat C, Curtis S, Spiliopoulou I, Bes M, Cocuzza C, Codita I, et al. MRSA infections among patients in the emergency department: a European multicentre study. J Antimicrob Chemother. 2017;72:372–5.PubMedCrossRef
40.
Zurück zum Zitat Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014;90:229–35.PubMed Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014;90:229–35.PubMed
41.
Zurück zum Zitat Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, et al. A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med. 2017;376:2545–55.PubMedPubMedCentralCrossRef Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, et al. A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med. 2017;376:2545–55.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Mounsey A, Lacy Smith K, Reddy VC, Nickolich S. Clostridioides difficile infection: update on management. Am Fam Physician. 2020;101:168–75.PubMed Mounsey A, Lacy Smith K, Reddy VC, Nickolich S. Clostridioides difficile infection: update on management. Am Fam Physician. 2020;101:168–75.PubMed
43.
Zurück zum Zitat Bowen AC, Tong SYC, Andrews RM, O’Meara IM, McDonald MI, Chatfield MD, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. 2014;384:2132–40.PubMedCrossRef Bowen AC, Tong SYC, Andrews RM, O’Meara IM, McDonald MI, Chatfield MD, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. 2014;384:2132–40.PubMedCrossRef
44.
Zurück zum Zitat Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374:823–32.PubMedPubMedCentralCrossRef Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374:823–32.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015;372:1093–103.PubMedPubMedCentralCrossRef Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015;372:1093–103.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Rae N, Jarchow-MacDonald A, Nathwani D, Marwick CA. MRSA: treating people with infection. BMJ Clin Evid. 2016;2016:0922.PubMedPubMedCentral Rae N, Jarchow-MacDonald A, Nathwani D, Marwick CA. MRSA: treating people with infection. BMJ Clin Evid. 2016;2016:0922.PubMedPubMedCentral
47.
Zurück zum Zitat Hua C, Urbina T, Bosc R, Parks T, Sriskandan S, de Prost N, et al. Necrotising soft-tissue infections. Lancet Infect Dis. 2023;23(3):e81-94.PubMedCrossRef Hua C, Urbina T, Bosc R, Parks T, Sriskandan S, de Prost N, et al. Necrotising soft-tissue infections. Lancet Infect Dis. 2023;23(3):e81-94.PubMedCrossRef
48.
Zurück zum Zitat Wang Z, Feig JL, Mannschreck DB, Cohen BA. Antibiotic sensitivity and clinical outcomes in staphylococcal scalded skin syndrome. Pediatr Dermatol. 2020;37:222–3.PubMedCrossRef Wang Z, Feig JL, Mannschreck DB, Cohen BA. Antibiotic sensitivity and clinical outcomes in staphylococcal scalded skin syndrome. Pediatr Dermatol. 2020;37:222–3.PubMedCrossRef
49.
Zurück zum Zitat Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120:10-22.e2.PubMedCrossRef Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120:10-22.e2.PubMedCrossRef
50.
Zurück zum Zitat Hung S-H, Lin Y-T, Chu C-Y, Lee C-C, Liang T-C, Yang Y-H, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98:51–6.PubMedCrossRef Hung S-H, Lin Y-T, Chu C-Y, Lee C-C, Liang T-C, Yang Y-H, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98:51–6.PubMedCrossRef
51.
Zurück zum Zitat Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75:481-93.e8.PubMedPubMedCentralCrossRef Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75:481-93.e8.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Callewaert C, Nakatsuji T, Knight R, Kosciolek T, Vrbanac A, Kotol P, et al. IL-4Rα blockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis. J Invest Dermatol. 2020;140:191-202.e7.PubMedCrossRef Callewaert C, Nakatsuji T, Knight R, Kosciolek T, Vrbanac A, Kotol P, et al. IL-4Rα blockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis. J Invest Dermatol. 2020;140:191-202.e7.PubMedCrossRef
53.
Zurück zum Zitat Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126:3–12.PubMedCrossRef Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126:3–12.PubMedCrossRef
54.
Zurück zum Zitat Magdaleno-Tapial J, Martínez-Doménech A, Valenzuela-Oñate C, Ferrer-Guillén B, Esteve-Martínez A, Zaragoza-Ninet V. Allergic contact dermatitis to chlorhexidine in pediatric patients. Pediatr Dermatol. 2019;36:540–1.PubMedCrossRef Magdaleno-Tapial J, Martínez-Doménech A, Valenzuela-Oñate C, Ferrer-Guillén B, Esteve-Martínez A, Zaragoza-Ninet V. Allergic contact dermatitis to chlorhexidine in pediatric patients. Pediatr Dermatol. 2019;36:540–1.PubMedCrossRef
55.
Zurück zum Zitat Hong F, Salmon S, Ong XY, Liew K, Koh Y, Young A, et al. Routine antiseptic baths and MRSA decolonization: diverse approaches across Singapore’s acute-care hospitals. J Hosp Infect. 2021;112:87–91.PubMedCrossRef Hong F, Salmon S, Ong XY, Liew K, Koh Y, Young A, et al. Routine antiseptic baths and MRSA decolonization: diverse approaches across Singapore’s acute-care hospitals. J Hosp Infect. 2021;112:87–91.PubMedCrossRef
56.
Zurück zum Zitat Chow A, Hon PY, Tin G, Zhang W, Poh BF, Ang B. Intranasal octenidine and universal antiseptic bathing reduce methicillin-resistant Staphylococcus aureus (MRSA) prevalence in extended care facilities. Epidemiol Infect. 2018;146:2036–41.PubMedPubMedCentralCrossRef Chow A, Hon PY, Tin G, Zhang W, Poh BF, Ang B. Intranasal octenidine and universal antiseptic bathing reduce methicillin-resistant Staphylococcus aureus (MRSA) prevalence in extended care facilities. Epidemiol Infect. 2018;146:2036–41.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Harris PNA, Le BD, Tambyah P, Hsu LY, Pada S, Archuleta S, et al. Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: a cluster crossover study. Open Forum Infect Dis. 2015;2:ofv051.PubMedPubMedCentralCrossRef Harris PNA, Le BD, Tambyah P, Hsu LY, Pada S, Archuleta S, et al. Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: a cluster crossover study. Open Forum Infect Dis. 2015;2:ofv051.PubMedPubMedCentralCrossRef
58.
Zurück zum Zitat Hardy K, Sunnucks K, Gil H, Shabir S, Trampari E, Hawkey P, et al. Increased usage of antiseptics is associated with reduced susceptibility in clinical isolates of Staphylococcus aureus. MBio. 2018;9: e00894-18.PubMedPubMedCentralCrossRef Hardy K, Sunnucks K, Gil H, Shabir S, Trampari E, Hawkey P, et al. Increased usage of antiseptics is associated with reduced susceptibility in clinical isolates of Staphylococcus aureus. MBio. 2018;9: e00894-18.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Chopra R, Vakharia PP, Sacotte R, Silverberg JI. Efficacy of bleach baths in reducing severity of atopic dermatitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2017;119:435–40.PubMedPubMedCentralCrossRef Chopra R, Vakharia PP, Sacotte R, Silverberg JI. Efficacy of bleach baths in reducing severity of atopic dermatitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2017;119:435–40.PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Takatsuji T, Gallo RL, Shafiq F, Tong Y, Chun K, Butcher AM, Cheng JY, Hata TR. Use of autologous bacteriotherapy to treat Staphylococcus aureus in patients with atopic dermatitis: a randomized double-blind clinical trial. JAMA Dermatol. 2021;157:978–82.CrossRef Takatsuji T, Gallo RL, Shafiq F, Tong Y, Chun K, Butcher AM, Cheng JY, Hata TR. Use of autologous bacteriotherapy to treat Staphylococcus aureus in patients with atopic dermatitis: a randomized double-blind clinical trial. JAMA Dermatol. 2021;157:978–82.CrossRef
61.
Zurück zum Zitat Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Hengge U, et al. Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin. Pediatr Dermatol. 2012;29:430–6.PubMedCrossRef Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Hengge U, et al. Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin. Pediatr Dermatol. 2012;29:430–6.PubMedCrossRef
62.
Zurück zum Zitat Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world: its prevalence, complications, and management. Clin Microbiol Infect. 2012;18:313–23.PubMedCrossRef Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world: its prevalence, complications, and management. Clin Microbiol Infect. 2012;18:313–23.PubMedCrossRef
63.
Zurück zum Zitat Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–94.PubMedCrossRef Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–94.PubMedCrossRef
64.
Zurück zum Zitat Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P, et al. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis. 2013;7: e2167.PubMedPubMedCentralCrossRef Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P, et al. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis. 2013;7: e2167.PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, et al. The public health control of scabies: priorities for research and action. Lancet. 2019;394:81–92.PubMedCrossRef Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, et al. The public health control of scabies: priorities for research and action. Lancet. 2019;394:81–92.PubMedCrossRef
66.
Zurück zum Zitat Streeton CL, Hanna JN, Messer RD, Merianos A. An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children. J Paediatr Child Health. 1995;31:245–8.PubMedCrossRef Streeton CL, Hanna JN, Messer RD, Merianos A. An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children. J Paediatr Child Health. 1995;31:245–8.PubMedCrossRef
67.
Zurück zum Zitat Thornley S, Marshall R, Jarrett P, Sundborn G, Reynolds E, Schofield G. Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. J Paediatr Child Health. 2018;54:625–32.PubMedCrossRef Thornley S, Marshall R, Jarrett P, Sundborn G, Reynolds E, Schofield G. Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. J Paediatr Child Health. 2018;54:625–32.PubMedCrossRef
68.
Zurück zum Zitat Steer AC, Jenney AWJ, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L, et al. High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis. 2009;3: e467.PubMedPubMedCentralCrossRef Steer AC, Jenney AWJ, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L, et al. High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis. 2009;3: e467.PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Jenney A, Holt D, Ritika R, Southwell P, Pravin S, Buadromo E, et al. The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji. BMC Infect Dis. 2014;14:160.PubMedPubMedCentralCrossRef Jenney A, Holt D, Ritika R, Southwell P, Pravin S, Buadromo E, et al. The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji. BMC Infect Dis. 2014;14:160.PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, et al. Prevalence of scabies and impetigo 3 years after mass drug administration with ivermectin and azithromycin. Clin Infect Dis. 2020;70:1591–5.PubMedCrossRef Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, et al. Prevalence of scabies and impetigo 3 years after mass drug administration with ivermectin and azithromycin. Clin Infect Dis. 2020;70:1591–5.PubMedCrossRef
71.
Zurück zum Zitat Skayem C, Majda A, Gary C, Hemery F, Mahé E, Caux F, et al. Severe scabies: a French multi-centre study involving 95 patients with crusted and profuse disease and review of the literature. Acta Derm Venereol. 2023;103:adv00878.PubMedCrossRef Skayem C, Majda A, Gary C, Hemery F, Mahé E, Caux F, et al. Severe scabies: a French multi-centre study involving 95 patients with crusted and profuse disease and review of the literature. Acta Derm Venereol. 2023;103:adv00878.PubMedCrossRef
72.
Zurück zum Zitat Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: scabies. J Am Acad Dermatol. 2020;82:533–48.PubMedCrossRef Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: scabies. J Am Acad Dermatol. 2020;82:533–48.PubMedCrossRef
73.
Zurück zum Zitat Reynolds SL, Pike RN, Mika A, Blom AM, Hofmann A, Wijeyewickrema LC, et al. Scabies mite inactive serine proteases are potent inhibitors of the human complement lectin pathway. PLoS Negl Trop Dis. 2014;8: e2872.PubMedPubMedCentralCrossRef Reynolds SL, Pike RN, Mika A, Blom AM, Hofmann A, Wijeyewickrema LC, et al. Scabies mite inactive serine proteases are potent inhibitors of the human complement lectin pathway. PLoS Negl Trop Dis. 2014;8: e2872.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Swe PM, Fischer K. A scabies mite serpin interferes with complement-mediated neutrophil functions and promotes staphylococcal growth. PLoS Negl Trop Dis. 2014;8: e2928.PubMedPubMedCentralCrossRef Swe PM, Fischer K. A scabies mite serpin interferes with complement-mediated neutrophil functions and promotes staphylococcal growth. PLoS Negl Trop Dis. 2014;8: e2928.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Swe PM, Christian LD, Lu HC, Sriprakash KS, Fischer K. Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes: an in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl Trop Dis. 2017;11: e0005437.PubMedPubMedCentralCrossRef Swe PM, Christian LD, Lu HC, Sriprakash KS, Fischer K. Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes: an in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl Trop Dis. 2017;11: e0005437.PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Swe PM, Zakrzewski M, Kelly A, Krause L, Fischer K. Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl Trop Dis. 2014;8: e2897.PubMedPubMedCentralCrossRef Swe PM, Zakrzewski M, Kelly A, Krause L, Fischer K. Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl Trop Dis. 2014;8: e2897.PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Yeoh DK, Bowen AC, Carapetis JR. Impetigo and scabies: disease burden and modern treatment strategies. J Infect. 2016;72(Suppl.):S61–7.PubMedCrossRef Yeoh DK, Bowen AC, Carapetis JR. Impetigo and scabies: disease burden and modern treatment strategies. J Infect. 2016;72(Suppl.):S61–7.PubMedCrossRef
78.
Zurück zum Zitat Thean LJ, Jenney A, Engelman D, Romani L, Wand H, Mudaliar J, et al. Hospital admissions for skin and soft tissue infections in a population with endemic scabies: a prospective study in Fiji, 2018–2019. PLoS Negl Trop Dis. 2020;14: e0008887.PubMedPubMedCentralCrossRef Thean LJ, Jenney A, Engelman D, Romani L, Wand H, Mudaliar J, et al. Hospital admissions for skin and soft tissue infections in a population with endemic scabies: a prospective study in Fiji, 2018–2019. PLoS Negl Trop Dis. 2020;14: e0008887.PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101:e119–25.PubMedCrossRef Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101:e119–25.PubMedCrossRef
80.
Zurück zum Zitat Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2018;378:971.PubMed Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2018;378:971.PubMed
81.
Zurück zum Zitat Salle R, Hua C, Mongereau M, Giraud-Kerleroux L, Gary C, Fiani C, et al. Challenges and limitations of teledermatology for skin and soft-tissue infections: a real-world study of an expert center. J Am Acad Dermatol. 2023;88:457–9.PubMedCrossRef Salle R, Hua C, Mongereau M, Giraud-Kerleroux L, Gary C, Fiani C, et al. Challenges and limitations of teledermatology for skin and soft-tissue infections: a real-world study of an expert center. J Am Acad Dermatol. 2023;88:457–9.PubMedCrossRef
82.
Zurück zum Zitat Andrews RM, Kearns T, Connors C, Parker C, Carville K, Currie BJ, et al. A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis. 2009;3: e554.PubMedPubMedCentralCrossRef Andrews RM, Kearns T, Connors C, Parker C, Carville K, Currie BJ, et al. A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis. 2009;3: e554.PubMedPubMedCentralCrossRef
83.
Zurück zum Zitat Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 2005;83:34–42.PubMedPubMedCentral Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 2005;83:34–42.PubMedPubMedCentral
84.
Zurück zum Zitat Burkhart CN, Burkhart CG. Fomite transmission in head lice. J Am Acad Dermatol. 2007;56:1044–7.PubMedCrossRef Burkhart CN, Burkhart CG. Fomite transmission in head lice. J Am Acad Dermatol. 2007;56:1044–7.PubMedCrossRef
86.
Zurück zum Zitat Nilsson SF, Ali Z, Laursen TM, Thyssen JP, Egeberg A, Nordentoft M, et al. Association of homelessness and skin conditions: a Danish population-based cohort study. Br J Dermatol. 2023;188:760–9.PubMedCrossRef Nilsson SF, Ali Z, Laursen TM, Thyssen JP, Egeberg A, Nordentoft M, et al. Association of homelessness and skin conditions: a Danish population-based cohort study. Br J Dermatol. 2023;188:760–9.PubMedCrossRef
87.
Zurück zum Zitat Chosidow O, Chang AY. The skin of people experiencing homelessness: more (known) is less (neglected). Br J Dermatol. 2023;188:694–5.PubMedCrossRef Chosidow O, Chang AY. The skin of people experiencing homelessness: more (known) is less (neglected). Br J Dermatol. 2023;188:694–5.PubMedCrossRef
88.
Zurück zum Zitat Arnaud A, Chosidow O, Détrez M-A, Bitar D, Huber F, Foulet F, et al. Prevalences of scabies and pediculosis corporis among homeless people in the Paris region: results from two randomized cross-sectional surveys (HYTPEAC study). Br J Dermatol. 2016;174:104–12.PubMedCrossRef Arnaud A, Chosidow O, Détrez M-A, Bitar D, Huber F, Foulet F, et al. Prevalences of scabies and pediculosis corporis among homeless people in the Paris region: results from two randomized cross-sectional surveys (HYTPEAC study). Br J Dermatol. 2016;174:104–12.PubMedCrossRef
89.
Zurück zum Zitat Bonilla DL, Cole-Porse C, Kjemtrup A, Osikowicz L, Kosoy M. Risk factors for human lice and bartonellosis among the homeless, San Francisco, California, USA. Emerg Infect Dis. 2014;20:1645–51.PubMedPubMedCentralCrossRef Bonilla DL, Cole-Porse C, Kjemtrup A, Osikowicz L, Kosoy M. Risk factors for human lice and bartonellosis among the homeless, San Francisco, California, USA. Emerg Infect Dis. 2014;20:1645–51.PubMedPubMedCentralCrossRef
90.
Zurück zum Zitat Drali R, Sangaré AK, Boutellis A, Angelakis E, Veracx A, Socolovschi C, et al. Bartonella quintana in body lice from scalp hair of homeless persons. France Emerg Infect Dis. 2014;20:907–8.PubMedCrossRef Drali R, Sangaré AK, Boutellis A, Angelakis E, Veracx A, Socolovschi C, et al. Bartonella quintana in body lice from scalp hair of homeless persons. France Emerg Infect Dis. 2014;20:907–8.PubMedCrossRef
91.
Zurück zum Zitat Faccini-Martínez ÁA, Márquez AC, Bravo-Estupiñan DM, Calixto O-J, López-Castillo CA, Botero-García CA, et al. Bartonella quintana and typhus group Rickettsiae exposure among homeless persons, Bogotá. Colombia Emerg Infect Dis. 2017;23:1876–9.PubMedCrossRef Faccini-Martínez ÁA, Márquez AC, Bravo-Estupiñan DM, Calixto O-J, López-Castillo CA, Botero-García CA, et al. Bartonella quintana and typhus group Rickettsiae exposure among homeless persons, Bogotá. Colombia Emerg Infect Dis. 2017;23:1876–9.PubMedCrossRef
92.
Zurück zum Zitat Ulutasdemir N, Eroglu F, Tanrıverdi M, Dagli EI, Koltas IS. The epidemic typhus and trench fever are risk for public health due to increased migration in southeast of Turkey. Acta Trop. 2018;178:115–8.PubMedCrossRef Ulutasdemir N, Eroglu F, Tanrıverdi M, Dagli EI, Koltas IS. The epidemic typhus and trench fever are risk for public health due to increased migration in southeast of Turkey. Acta Trop. 2018;178:115–8.PubMedCrossRef
93.
Zurück zum Zitat Louni M, Mana N, Bitam I, Dahmani M, Parola P, Fenollar F, et al. Body lice of homeless people reveal the presence of several emerging bacterial pathogens in northern Algeria. PLoS Negl Trop Dis. 2018;12: e0006397.PubMedPubMedCentralCrossRef Louni M, Mana N, Bitam I, Dahmani M, Parola P, Fenollar F, et al. Body lice of homeless people reveal the presence of several emerging bacterial pathogens in northern Algeria. PLoS Negl Trop Dis. 2018;12: e0006397.PubMedPubMedCentralCrossRef
94.
Zurück zum Zitat Antinori S, Mediannikov O, Corbellino M, Raoult D. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis. 2016;14:110–4.PubMedCrossRef Antinori S, Mediannikov O, Corbellino M, Raoult D. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis. 2016;14:110–4.PubMedCrossRef
95.
Zurück zum Zitat Nordmann T, Feldt T, Bosselmann M, Tufa TB, Lemma G, Holtfreter M, et al. Outbreak of louse-borne relapsing fever among urban dwellers in Arsi zone, Central Ethiopia, from July to November 2016. Am J Trop Med Hyg. 2018;98:1599–602.PubMedPubMedCentralCrossRef Nordmann T, Feldt T, Bosselmann M, Tufa TB, Lemma G, Holtfreter M, et al. Outbreak of louse-borne relapsing fever among urban dwellers in Arsi zone, Central Ethiopia, from July to November 2016. Am J Trop Med Hyg. 2018;98:1599–602.PubMedPubMedCentralCrossRef
96.
Zurück zum Zitat Karunamoorthi K. Tungiasis: a neglected epidermal parasitic skin disease of marginalized populations—a call for global science and policy. Parasitol Res. 2013;112:3635–43.PubMedCrossRef Karunamoorthi K. Tungiasis: a neglected epidermal parasitic skin disease of marginalized populations—a call for global science and policy. Parasitol Res. 2013;112:3635–43.PubMedCrossRef
97.
Zurück zum Zitat Feldmeier H, Heukelbach J, Eisele M, Sousa AQ, Barbosa LM, Carvalho CB. Bacterial superinfection in human tungiasis. Trop Med Int Health. 2002;7:559–64.PubMedCrossRef Feldmeier H, Heukelbach J, Eisele M, Sousa AQ, Barbosa LM, Carvalho CB. Bacterial superinfection in human tungiasis. Trop Med Int Health. 2002;7:559–64.PubMedCrossRef
98.
Zurück zum Zitat Nyangacha RM, Odongo D, Oyieke F, Ochwoto M, Korir R, Ngetich RK, et al. Secondary bacterial infections and antibiotic resistance among tungiasis patients in Western, Kenya. PLoS Negl Trop Dis. 2017;11: e0005901.PubMedPubMedCentralCrossRef Nyangacha RM, Odongo D, Oyieke F, Ochwoto M, Korir R, Ngetich RK, et al. Secondary bacterial infections and antibiotic resistance among tungiasis patients in Western, Kenya. PLoS Negl Trop Dis. 2017;11: e0005901.PubMedPubMedCentralCrossRef
99.
Zurück zum Zitat Coates SJ, Thomas C, Chosidow O, Engelman D, Chang AY. Ectoparasites: pediculosis and tungiasis. J Am Acad Dermatol. 2020;82:551–69.PubMedCrossRef Coates SJ, Thomas C, Chosidow O, Engelman D, Chang AY. Ectoparasites: pediculosis and tungiasis. J Am Acad Dermatol. 2020;82:551–69.PubMedCrossRef
100.
101.
Zurück zum Zitat Rolain J-M, Foucault C, Guieu R, La Scola B, Brouqui P, Raoult D. Bartonella quintana in human erythrocytes. Lancet. 2002;360:226–8.PubMedCrossRef Rolain J-M, Foucault C, Guieu R, La Scola B, Brouqui P, Raoult D. Bartonella quintana in human erythrocytes. Lancet. 2002;360:226–8.PubMedCrossRef
104.
Zurück zum Zitat Badiaga S, Brouqui P. Human louse-transmitted infectious diseases. Clin Microbiol Infect. 2012;18:332–7.PubMedCrossRef Badiaga S, Brouqui P. Human louse-transmitted infectious diseases. Clin Microbiol Infect. 2012;18:332–7.PubMedCrossRef
105.
Zurück zum Zitat Jenkins NE, Ferguson DJP, Alp NJ, Harrison TG, Bowler ICJW. Urban trench fever presenting as culture-negative endocarditis. QJM. 2009;102:63–5.PubMedCrossRef Jenkins NE, Ferguson DJP, Alp NJ, Harrison TG, Bowler ICJW. Urban trench fever presenting as culture-negative endocarditis. QJM. 2009;102:63–5.PubMedCrossRef
106.
Zurück zum Zitat Moulin C, Kanitakis J, Ranchin B, Chauvet C, Gillet Y, Morelon E, et al. Cutaneous bacillary angiomatosis in renal transplant recipients: report of three new cases and literature review. Transpl Infect Dis. 2012;14:403–9.PubMedCrossRef Moulin C, Kanitakis J, Ranchin B, Chauvet C, Gillet Y, Morelon E, et al. Cutaneous bacillary angiomatosis in renal transplant recipients: report of three new cases and literature review. Transpl Infect Dis. 2012;14:403–9.PubMedCrossRef
107.
Zurück zum Zitat Raoult D, Ndihokubwayo JB, Tissot-Dupont H, Roux V, Faugere B, Abegbinni R, et al. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet. 1998;352:353–8.PubMedCrossRef Raoult D, Ndihokubwayo JB, Tissot-Dupont H, Roux V, Faugere B, Abegbinni R, et al. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet. 1998;352:353–8.PubMedCrossRef
109.
Zurück zum Zitat Mitjà O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH, et al. Integrated control and management of neglected tropical skin diseases. PLoS Negl Trop Dis. 2017;11: e0005136.PubMedPubMedCentralCrossRef Mitjà O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH, et al. Integrated control and management of neglected tropical skin diseases. PLoS Negl Trop Dis. 2017;11: e0005136.PubMedPubMedCentralCrossRef
110.
Zurück zum Zitat La Scola B, Raoult D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol. 1999;37:1899–905.PubMedPubMedCentralCrossRef La Scola B, Raoult D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol. 1999;37:1899–905.PubMedPubMedCentralCrossRef
111.
Zurück zum Zitat Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents. 2014;44:16–25.PubMedCrossRef Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents. 2014;44:16–25.PubMedCrossRef
112.
113.
Zurück zum Zitat Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15:645–57.PubMedCrossRef Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15:645–57.PubMedCrossRef
114.
Zurück zum Zitat Bozzola E, Bozzola M, Krzysztofiak A, Tozzi AE, El Hachem M, Villani A. Varicella skin complications in childhood: a case series and a systematic review of the literature. Int J Mol Sci. 2016;17:688.PubMedPubMedCentralCrossRef Bozzola E, Bozzola M, Krzysztofiak A, Tozzi AE, El Hachem M, Villani A. Varicella skin complications in childhood: a case series and a systematic review of the literature. Int J Mol Sci. 2016;17:688.PubMedPubMedCentralCrossRef
115.
Zurück zum Zitat Diniz LMO, Maia MMM, de Oliveira YV, Mourão MSF, Couto AV, Mota VC, et al. Study of complications of varicella-zoster virus infection in hospitalized children at a reference hospital for infectious disease treatment. Hosp Pediatr. 2018;8:419–25.PubMedCrossRef Diniz LMO, Maia MMM, de Oliveira YV, Mourão MSF, Couto AV, Mota VC, et al. Study of complications of varicella-zoster virus infection in hospitalized children at a reference hospital for infectious disease treatment. Hosp Pediatr. 2018;8:419–25.PubMedCrossRef
116.
Zurück zum Zitat Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335:547–54.PubMedCrossRef Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335:547–54.PubMedCrossRef
117.
Zurück zum Zitat Babamahmoodi F, Alikhani A, Ahangarkani F, Delavarian L, Barani H, Babamahmoodi A. Clinical manifestations of herpes zoster, its comorbidities, and its complications in North of Iran from 2007 to 2013. Neurol Res Int. 2015;2015: 896098.PubMedPubMedCentral Babamahmoodi F, Alikhani A, Ahangarkani F, Delavarian L, Barani H, Babamahmoodi A. Clinical manifestations of herpes zoster, its comorbidities, and its complications in North of Iran from 2007 to 2013. Neurol Res Int. 2015;2015: 896098.PubMedPubMedCentral
118.
Zurück zum Zitat Bieńkowski C, Talarek E, Pokorska-Śpiewak M. The clinical course of herpes zoster is similar in immunocompetent and immunocompromised paediatric patients. J Paediatr Child Health. 2023;59:1112–4.PubMedCrossRef Bieńkowski C, Talarek E, Pokorska-Śpiewak M. The clinical course of herpes zoster is similar in immunocompetent and immunocompromised paediatric patients. J Paediatr Child Health. 2023;59:1112–4.PubMedCrossRef
119.
Zurück zum Zitat Dubos F, Grandbastien B, Hue V, Hospital Network for Evaluating Management of Common Childhood Diseases, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect. 2007;135:131–8.PubMedCrossRef Dubos F, Grandbastien B, Hue V, Hospital Network for Evaluating Management of Common Childhood Diseases, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect. 2007;135:131–8.PubMedCrossRef
120.
Zurück zum Zitat Elena B, Anna Q, Andrzej K, Elisabetta P, Laura L, Alberto T. Haematological complications in otherwise healthy children hospitalized for varicella. Vaccine. 2011;29:1534–7.PubMedCrossRef Elena B, Anna Q, Andrzej K, Elisabetta P, Laura L, Alberto T. Haematological complications in otherwise healthy children hospitalized for varicella. Vaccine. 2011;29:1534–7.PubMedCrossRef
121.
Zurück zum Zitat Veraldi S, Schianchi R. Herpes zoster, bacterial superinfections and antibiotics. J Dermatolog Treat. 2007;18:255.PubMedCrossRef Veraldi S, Schianchi R. Herpes zoster, bacterial superinfections and antibiotics. J Dermatolog Treat. 2007;18:255.PubMedCrossRef
122.
Zurück zum Zitat Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nat Rev Dis Prim. 2015;1:15016.PubMedCrossRef Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nat Rev Dis Prim. 2015;1:15016.PubMedCrossRef
123.
Zurück zum Zitat Dauger S, Blondé R, Brissaud O, Marcoux M-O, Angoulvant F, Levy M, et al. Necrotizing soft-tissue infections in pediatric intensive care: a prospective multicenter case-series study. Crit Care. 2021;25:139.PubMedPubMedCentralCrossRef Dauger S, Blondé R, Brissaud O, Marcoux M-O, Angoulvant F, Levy M, et al. Necrotizing soft-tissue infections in pediatric intensive care: a prospective multicenter case-series study. Crit Care. 2021;25:139.PubMedPubMedCentralCrossRef
125.
Zurück zum Zitat Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics. 1999;103:783–90.PubMedCrossRef Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics. 1999;103:783–90.PubMedCrossRef
126.
Zurück zum Zitat Weidner T, Tittelbach J, Illing T, Elsner P. Gram-negative bacterial toe web infection: a systematic review. J Eur Acad Dermatol Venereol. 2018;32:39–47.PubMedCrossRef Weidner T, Tittelbach J, Illing T, Elsner P. Gram-negative bacterial toe web infection: a systematic review. J Eur Acad Dermatol Venereol. 2018;32:39–47.PubMedCrossRef
127.
Zurück zum Zitat Goiset A, Milpied B, Marti A, Marie J, Leroy-Colavolpe V, Pham-Ledard A, et al. Characteristics, associated diseases, and management of Gram-negative toe-web infection: a French experience. Acta Derm Venereol. 2019;99:1121–6.PubMed Goiset A, Milpied B, Marti A, Marie J, Leroy-Colavolpe V, Pham-Ledard A, et al. Characteristics, associated diseases, and management of Gram-negative toe-web infection: a French experience. Acta Derm Venereol. 2019;99:1121–6.PubMed
128.
Zurück zum Zitat Solomon M, Greenbaum H, Shemer A, Barzilai A, Baum S. Toe web infection: epidemiology and risk factors in a large cohort study. Dermatology. 2021;237:902–6.PubMedCrossRef Solomon M, Greenbaum H, Shemer A, Barzilai A, Baum S. Toe web infection: epidemiology and risk factors in a large cohort study. Dermatology. 2021;237:902–6.PubMedCrossRef
129.
Zurück zum Zitat Leyden JJ, Kligman AM. Interdigital athlete’s foot: the interaction of dermatophytes and resident bacteria. Arch Dermatol. 1978;114:1466–72.PubMedCrossRef Leyden JJ, Kligman AM. Interdigital athlete’s foot: the interaction of dermatophytes and resident bacteria. Arch Dermatol. 1978;114:1466–72.PubMedCrossRef
130.
Zurück zum Zitat Hojyo-Tomoka MT, Marples RR, Kligman AM. Pseudomonas infection in superhydrated skin. Arch Dermatol. 1973;107:723–7.PubMedCrossRef Hojyo-Tomoka MT, Marples RR, Kligman AM. Pseudomonas infection in superhydrated skin. Arch Dermatol. 1973;107:723–7.PubMedCrossRef
131.
Zurück zum Zitat Aste N, Atzori L, Zucca M, Pau M, Biggio P. Gram-negative bacterial toe web infection: a survey of 123 cases from the district of Cagliari. Italy J Am Acad Dermatol. 2001;45:537–41.PubMedCrossRef Aste N, Atzori L, Zucca M, Pau M, Biggio P. Gram-negative bacterial toe web infection: a survey of 123 cases from the district of Cagliari. Italy J Am Acad Dermatol. 2001;45:537–41.PubMedCrossRef
132.
Zurück zum Zitat Gupta AK, Skinner AR, Cooper EA. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. Int J Dermatol. 2005;44:590–3.PubMedCrossRef Gupta AK, Skinner AR, Cooper EA. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. Int J Dermatol. 2005;44:590–3.PubMedCrossRef
133.
Zurück zum Zitat Kim M-C, Kim S, Cho EB, Lee GY, Choi S-H, Kim SO, et al. Utility of magnetic resonance imaging for differentiating necrotizing fasciitis from severe cellulitis: a magnetic resonance indicator for necrotizing fasciitis (MRINEC) algorithm. J Clin Med. 2020;9:3040.PubMedPubMedCentralCrossRef Kim M-C, Kim S, Cho EB, Lee GY, Choi S-H, Kim SO, et al. Utility of magnetic resonance imaging for differentiating necrotizing fasciitis from severe cellulitis: a magnetic resonance indicator for necrotizing fasciitis (MRINEC) algorithm. J Clin Med. 2020;9:3040.PubMedPubMedCentralCrossRef
134.
Zurück zum Zitat Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Raşa K, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58.PubMedPubMedCentralCrossRef Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Raşa K, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58.PubMedPubMedCentralCrossRef
135.
Zurück zum Zitat Babiker A, Li X, Lai YL, Strich JR, Warner S, Sarzynski S, et al. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis. 2021;21:697–710.PubMedCrossRef Babiker A, Li X, Lai YL, Strich JR, Warner S, Sarzynski S, et al. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis. 2021;21:697–710.PubMedCrossRef
136.
Zurück zum Zitat Salle R, Chosidow O, Fihman V, de Prost N, Zeghbib N, Woerther P-L, et al. Clindamycin resistance in Group A streptococcal infections: a single-centre retrospective cohort study of 186 patients. J Eur Acad Dermatol Venereol. 2023;37:e888–9.PubMedCrossRef Salle R, Chosidow O, Fihman V, de Prost N, Zeghbib N, Woerther P-L, et al. Clindamycin resistance in Group A streptococcal infections: a single-centre retrospective cohort study of 186 patients. J Eur Acad Dermatol Venereol. 2023;37:e888–9.PubMedCrossRef
Metadaten
Titel
Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses
verfasst von
Romain Salle
Pascal Del Giudice
Charbel Skayem
Camille Hua
Olivier Chosidow
Publikationsdatum
05.04.2024
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-024-00856-1

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.